Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Idebenone (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms IPPOMS
- 23 Sep 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Jan 2018.
- 05 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Apr 2015 According to a Santhera Pharmaceuticals media release, the enrolment for this trial has been completed.